| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/19/2009 | CA2698977A1 Use of c-type natriuretic peptide, alone or incombination with neuropeptide af, as a therapeutic agent |
| 03/19/2009 | CA2698976A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698974A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698971A1 Use of urodilatin as a therapeutic agent |
| 03/19/2009 | CA2698966A1 Use of fertirelin and delta-endorphin as therapeutic agents |
| 03/19/2009 | CA2698963A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698912A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698855A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698852A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698833A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698831A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698828A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698824A1 Use of peptide yy, alone or in combination with glucagon-like peptide, for use in medicine |
| 03/19/2009 | CA2698822A1 Minigastrin as a therapeutic agent |
| 03/19/2009 | CA2698821A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698786A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698783A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698778A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698770A1 Use of secretin and optionally urodilatin as a therapeutic agents |
| 03/19/2009 | CA2698759A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698754A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698748A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698745A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698693A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698691A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698682A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698666A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698471A1 Substituted 6-phenylnicotinic acids and the use thereof |
| 03/18/2009 | EP2036916A1 Composition for promoting the production of equol |
| 03/18/2009 | EP2036905A1 Pyridylisoxazole derivative |
| 03/18/2009 | EP2036901A1 C-phenyl 1-thioglucitol compound |
| 03/18/2009 | EP2036895A1 Hsp90 inhibitor |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036888A1 Naphthyl-substituted sulfonamides |
| 03/18/2009 | EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 03/18/2009 | EP2036564A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 03/18/2009 | EP2036554A1 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment for diabetes mellitus |
| 03/18/2009 | EP2036541A1 Methods and compositions for pulmonary delivery of insulin |
| 03/18/2009 | EP2035429A1 FUSED [d]PYRIDAZIN-7-ONES |
| 03/18/2009 | EP2035417A1 Benzimidazoles and their use for the treatemnt of diabetes |
| 03/18/2009 | EP2035397A1 Chemical compounds |
| 03/18/2009 | EP2035379A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 03/18/2009 | EP2035013A1 Use of defibrotide for the inhibition of heparanase |
| 03/18/2009 | EP2034987A1 New use for cannabinoid |
| 03/18/2009 | EP2034983A1 Use of a polyunsaturated fatty acid compound |
| 03/18/2009 | EP2000137A9 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
| 03/18/2009 | EP1567493B1 Phenyl substituted piperidine compounds for use as ppar activators |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1448993B1 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules |
| 03/18/2009 | EP1333816B1 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same |
| 03/18/2009 | EP1292294B1 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease |
| 03/18/2009 | EP1218498B1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 03/18/2009 | CN101389606A Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (CETP) |
| 03/18/2009 | CN101389353A Enteric gelatinous nutrient and method of preparing the same |
| 03/18/2009 | CN101389348A A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| 03/18/2009 | CN101389339A Therapeutic agent for diabetes |
| 03/18/2009 | CN101389326A Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives |
| 03/18/2009 | CN101389322A Use of dha and ara in the preparation of a composition for preventing or treating obesity |
| 03/18/2009 | CN101389321A Use of resveratrol and derivatives thereof for promoting the wellness state in mammals |
| 03/18/2009 | CN101386875A Synthesis of conjugate linoleate sugar esters derivates based on enzymatic method |
| 03/18/2009 | CN101386618A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 03/18/2009 | CN101386617A Substituted tetrahydroisoquinoline derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 03/18/2009 | CN101386594A 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/18/2009 | CN101386592A Method for preparing pitavastatin calcium raw material medicine using asymmetric hydrogenation |
| 03/18/2009 | CN101385835A Traditional Chinese medicine health-care function pants |
| 03/18/2009 | CN101385813A Preparation method of medicine for reducing blood fat and cholesterol |
| 03/18/2009 | CN101385807A Use of rehmannia root whole crude medicine in preventing and treating hyperlipemia and hyperglycaemia |
| 03/18/2009 | CN101385804A New use of traditional Chinese medicine formulation |
| 03/18/2009 | CN101385785A Traditional Chinese medicine composition for treating hyperlipemia, preparation and quality control method thereof |
| 03/18/2009 | CN101385780A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385779A Medicament composition for preventing the birth defect and improving the memory and intelligence |
| 03/18/2009 | CN101385771A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385761A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385760A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385759A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385758A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385757A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385756A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385755A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385754A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385753A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385752A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385751A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385744A Preparation method of medicine for replenishing calcium |
| 03/18/2009 | CN101385731A Osmotic pump controlled release preparation composition for treating hyperlipemia and preparation method thereof |
| 03/18/2009 | CN101385730A Osmotic pump controlled release preparation composition for treating hyperlipemia and preparation method thereof |
| 03/18/2009 | CN101385729A Osmotic pump controlled release preparation composition for treating hyperlipemia and preparation method thereof |
| 03/18/2009 | CN101385723A Association between an anti-atherothrombotic and an angiotensin conversion enzyme inhibitor |
| 03/18/2009 | CN101385719A Osmotic pump preparation composition for treating hyperlipemia |
| 03/18/2009 | CN101385718A Osmotic pump preparation composition for treating hyperlipemia |
| 03/18/2009 | CN101385714A Preparation method of DHA lipid nano-particles |
| 03/18/2009 | CN101385536A Natural plant hypoglycemic effervescent beverages |
| 03/18/2009 | CN100469792C Regulation of lipid levels via the Zmaxl or HBM gene |
| 03/18/2009 | CN100469791C Glucagon-like peptide-1 analogs |
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/18/2009 | CN100469770C 5-substituted-pyrazine or -pyridine glucokinase activators |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469764C Vitamin D derivatives |